Cliff Asness's NVO Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 181,129 shares of Novo Nordisk A/S (NVO) worth $6.66 M, representing 0.00% of the portfolio. First purchased in 2023-Q3, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in NVO, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 63,351 shares. Largest reduction occurred in Q3 2025, reducing 1,655 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Novo Nordisk A/S (NVO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novo Nordisk A/S (NVO) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +39,719 | Add 28.09% | 181,129 | $36.75 |
| Q4 2025 | +17,615 | Add 14.23% | 141,410 | $50.88 |
| Q3 2025 | -1,655 | Reduce 1.32% | 123,795 | $55.49 |
| Q2 2025 | +63,351 | Add 102.02% | 125,450 | $69.02 |
| Q1 2025 | +10,758 | Add 20.95% | 62,099 | $69.44 |
| Q4 2024 | +353 | Add 0.69% | 51,341 | $86.02 |
| Q3 2024 | +33,824 | Add 197.06% | 50,988 | $119.07 |
| Q2 2024 | +9,012 | Add 110.55% | 17,164 | $142.73 |
| Q1 2024 | +2,990 | Add 57.92% | 8,152 | $128.40 |
| Q4 2023 | -133 | Reduce 2.51% | 5,162 | $103.45 |
| Q3 2023 | +5,295 | New Buy | 5,295 | $90.94 |
Cliff Asness's Novo Nordisk A/S Investment FAQs
Cliff Asness first purchased Novo Nordisk A/S (NVO) in Q3 2023, acquiring 5,295 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Novo Nordisk A/S (NVO) for 11 quarters since Q3 2023.
Cliff Asness's largest addition to Novo Nordisk A/S (NVO) was in Q2 2025, adding 125,450 shares worth $8.66 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 181,129 shares of Novo Nordisk A/S (NVO), valued at approximately $6.66 M.
As of the Q1 2026 filing, Novo Nordisk A/S (NVO) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Novo Nordisk A/S (NVO) was 181,129 shares, as reported at the end of Q1 2026.